Global Gene Synthesis Service Market Intelligence Brief (2026–2036)
Market Overview
The global Gene Synthesis Service Market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Gene synthesis services enable the custom design and assembly of DNA sequences, supporting applications in drug discovery, synthetic biology, vaccine development, and agricultural biotechnology. Rising demand for precision medicine, CRISPR-based research, and biopharma innovation is fueling market growth.
Impact of COVID-19
- Temporary disruption in laboratory operations and supply chains in 2020.
- Post-pandemic recovery driven by accelerated vaccine development, genomic research, and biopharma investments.
- Increased adoption of outsourced gene synthesis services to reduce costs and improve turnaround times.
Market Segmentation
By Type
- Below 1000 bp
- 1001 to 3000 bp
- 3001 to 5000 bp
- Above 5000 bp
- Custom Gene Libraries (emerging category)
By Application
- Commercial (biopharma, biotech companies, CROs)
- Academic Research (universities, research institutes)
- Clinical Diagnostics (genomic testing, personalized medicine)
- Agricultural Biotechnology (crop improvement, GMO research)
Regional Analysis
- North America: Largest market; U.S. leads with strong adoption in biopharma, NIH-backed genomic projects, and advanced synthetic biology infrastructure.
- Europe: Germany, UK, France, and Italy drive demand; EU initiatives encourage precision medicine and biotech innovation.
- Asia-Pacific: Fastest-growing region; China, India, and Japan investing heavily in biotech R&D, gene editing, and affordable synthesis services.
- South America: Brazil and Argentina leading; adoption in agricultural biotechnology and academic research.
- Middle East & Africa: Emerging demand in UAE, Saudi Arabia, and South Africa; driven by healthcare modernization and genomic medicine initiatives.
Key Players
- Genescript
- GeneArt (Thermo Fisher Scientific)
- Integrated DNA Technologies (IDT)
- Eurofins Genomics
- DNA 2.0 (ATUM)
- BBI
- Genewiz
- Gene Oracle
- SBS Genetech
- Bio Basic
Additional Players:
- Twist Bioscience
- Synbio Technologies
- OriGene Technologies
- Blue Heron Biotechnology
- Aldevron (part of Danaher)
- Evonetix Ltd.
- Molecular Assemblies Inc.
- Codex DNA Inc.
- Scarab Genomics
- Entelechon GmbH
Porter’s Five Forces
- Competitive Rivalry – High; multiple global and regional players, strong differentiation in turnaround time and accuracy.
- Threat of New Entrants – Moderate; high R&D costs and IP barriers limit entry.
- Bargaining Power of Suppliers – Moderate; reliance on reagents, enzymes, and sequencing technologies.
- Bargaining Power of Buyers – High; biotech firms and academic labs demand affordability, speed, and customization.
- Threat of Substitutes – Moderate; alternatives include in-house synthesis, but outsourcing remains cost-effective.
SWOT Analysis
Strengths
- Essential for synthetic biology and drug discovery.
- Wide range of applications across industries.
- Strong demand from biopharma and academic research.
Weaknesses
- High cost of long-sequence synthesis.
- Limited awareness in low-income regions.
Opportunities
- Expansion in emerging markets.
- Growth in CRISPR and gene-editing applications.
- Integration with AI-driven sequence design.
Threats
- Stringent regulatory frameworks.
- Rising competition in low-cost providers.
- Biosecurity concerns in synthetic biology.
Trend Analysis
- CRISPR & Gene Editing: Rising demand for custom sequences.
- AI-Driven Design: Advanced algorithms for optimized gene synthesis.
- Synthetic Biology Expansion: Growth in bio-based materials and fuels.
- Personalized Medicine: Tailored gene sequences for diagnostics and therapeutics.
- Automation & Robotics: Streamlining synthesis workflows for faster delivery.
Drivers
- Rising demand for synthetic biology and precision medicine.
- Increasing biopharma R&D investments.
- Technological innovation in DNA synthesis and sequencing.
- Expansion of academic and commercial collaborations.
Challenges
- High cost of long and complex gene sequences.
- Regulatory hurdles in synthetic biology applications.
- Biosecurity risks and ethical concerns.
- Limited infrastructure in developing regions.
Value Chain Analysis
- Raw Materials: Reagents, enzymes, nucleotides.
- Manufacturing: Gene assembly, sequencing, quality control.
- Distribution: Biopharma companies, academic labs, CROs.
- End-Users: Researchers, clinicians, biotech firms.
- After-Sales Services: Technical support, compliance monitoring, bioinformatics integration.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in automation and AI-driven synthesis; expand affordable services for emerging markets.
- Investors: Target Asia-Pacific and Middle East regions with strong biotech growth.
- Policy Makers: Strengthen biosecurity regulations and support synthetic biology initiatives.
- Healthcare Providers: Adopt gene synthesis for personalized medicine and diagnostics.
- Research Institutes: Expand R&D in CRISPR, synthetic biology, and AI-driven gene design.
Explore more reports here-
https://westernmarketresearch.com/reports
1. Market Overview of Gene Synthesis Service
1.1 Gene Synthesis Service Market Overview
1.1.1 Gene Synthesis Service Product Scope
1.1.2 Market Status and Outlook
1.2 Gene Synthesis Service Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Gene Synthesis Service Historic Market Size by Regions
1.4 Gene Synthesis Service Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Gene Synthesis Service Sales Market by Type
2.1 Global Gene Synthesis Service Historic Market Size by Type
2.2 Global Gene Synthesis Service Forecasted Market Size by Type
2.3 Below 1000 bp
2.4 1001 to 3000 bp
2.5 3001 to 5000 bp
2.6 Above 5000 bp
3. Covid-19 Impact Gene Synthesis Service Sales Market by Application
3.1 Global Gene Synthesis Service Historic Market Size by Application
3.2 Global Gene Synthesis Service Forecasted Market Size by Application
3.3 Commercial
3.4 Academic Research
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Gene Synthesis Service Production Capacity Market Share by Manufacturers
4.2 Global Gene Synthesis Service Revenue Market Share by Manufacturers
4.3 Global Gene Synthesis Service Average Price by Manufacturers
5. Company Profiles and Key Figures in Gene Synthesis Service Business
5.1 Genescript
5.1.1 Genescript Company Profile
5.1.2 Genescript Gene Synthesis Service Product Specification
5.1.3 Genescript Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.2 GeneArt (Thermofischer)
5.2.1 GeneArt (Thermofischer) Company Profile
5.2.2 GeneArt (Thermofischer) Gene Synthesis Service Product Specification
5.2.3 GeneArt (Thermofischer) Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.3 IDT
5.3.1 IDT Company Profile
5.3.2 IDT Gene Synthesis Service Product Specification
5.3.3 IDT Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.4 Eurofins Genomics
5.4.1 Eurofins Genomics Company Profile
5.4.2 Eurofins Genomics Gene Synthesis Service Product Specification
5.4.3 Eurofins Genomics Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.5 DNA 2.0 (ATUM)
5.5.1 DNA 2.0 (ATUM) Company Profile
5.5.2 DNA 2.0 (ATUM) Gene Synthesis Service Product Specification
5.5.3 DNA 2.0 (ATUM) Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.6 BBI
5.6.1 BBI Company Profile
5.6.2 BBI Gene Synthesis Service Product Specification
5.6.3 BBI Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.7 Genewiz
5.7.1 Genewiz Company Profile
5.7.2 Genewiz Gene Synthesis Service Product Specification
5.7.3 Genewiz Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.8 Gene Oracle
5.8.1 Gene Oracle Company Profile
5.8.2 Gene Oracle Gene Synthesis Service Product Specification
5.8.3 Gene Oracle Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.9 SBS Genetech
5.9.1 SBS Genetech Company Profile
5.9.2 SBS Genetech Gene Synthesis Service Product Specification
5.9.3 SBS Genetech Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
5.10 Bio Basic
5.10.1 Bio Basic Company Profile
5.10.2 Bio Basic Gene Synthesis Service Product Specification
5.10.3 Bio Basic Gene Synthesis Service Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Gene Synthesis Service Market Size
6.2 North America Gene Synthesis Service Key Players in North America
6.3 North America Gene Synthesis Service Market Size by Type
6.4 North America Gene Synthesis Service Market Size by Application
7. East Asia
7.1 East Asia Gene Synthesis Service Market Size
7.2 East Asia Gene Synthesis Service Key Players in North America
7.3 East Asia Gene Synthesis Service Market Size by Type
7.4 East Asia Gene Synthesis Service Market Size by Application
8. Europe
8.1 Europe Gene Synthesis Service Market Size
8.2 Europe Gene Synthesis Service Key Players in North America
8.3 Europe Gene Synthesis Service Market Size by Type
8.4 Europe Gene Synthesis Service Market Size by Application
9. South Asia
9.1 South Asia Gene Synthesis Service Market Size
9.2 South Asia Gene Synthesis Service Key Players in North America
9.3 South Asia Gene Synthesis Service Market Size by Type
9.4 South Asia Gene Synthesis Service Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Gene Synthesis Service Market Size
10.2 Southeast Asia Gene Synthesis Service Key Players in North America
10.3 Southeast Asia Gene Synthesis Service Market Size by Type
10.4 Southeast Asia Gene Synthesis Service Market Size by Application
11. Middle East
11.1 Middle East Gene Synthesis Service Market Size
11.2 Middle East Gene Synthesis Service Key Players in North America
11.3 Middle East Gene Synthesis Service Market Size by Type
11.4 Middle East Gene Synthesis Service Market Size by Application
12. Africa
12.1 Africa Gene Synthesis Service Market Size
12.2 Africa Gene Synthesis Service Key Players in North America
12.3 Africa Gene Synthesis Service Market Size by Type
12.4 Africa Gene Synthesis Service Market Size by Application
13. Oceania
13.1 Oceania Gene Synthesis Service Market Size
13.2 Oceania Gene Synthesis Service Key Players in North America
13.3 Oceania Gene Synthesis Service Market Size by Type
13.4 Oceania Gene Synthesis Service Market Size by Application
14. South America
14.1 South America Gene Synthesis Service Market Size
14.2 South America Gene Synthesis Service Key Players in North America
14.3 South America Gene Synthesis Service Market Size by Type
14.4 South America Gene Synthesis Service Market Size by Application
15. Rest of the World
15.1 Rest of the World Gene Synthesis Service Market Size
15.2 Rest of the World Gene Synthesis Service Key Players in North America
15.3 Rest of the World Gene Synthesis Service Market Size by Type
15.4 Rest of the World Gene Synthesis Service Market Size by Application
16 Gene Synthesis Service Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Market Segmentation
By Type
- Below 1000 bp
- 1001 to 3000 bp
- 3001 to 5000 bp
- Above 5000 bp
- Custom Gene Libraries (emerging category)
By Application
- Commercial (biopharma, biotech companies, CROs)
- Academic Research (universities, research institutes)
- Clinical Diagnostics (genomic testing, personalized medicine)
- Agricultural Biotechnology (crop improvement, GMO research)
Regional Analysis
- North America: Largest market; U.S. leads with strong adoption in biopharma, NIH-backed genomic projects, and advanced synthetic biology infrastructure.
- Europe: Germany, UK, France, and Italy drive demand; EU initiatives encourage precision medicine and biotech innovation.
- Asia-Pacific: Fastest-growing region; China, India, and Japan investing heavily in biotech R&D, gene editing, and affordable synthesis services.
- South America: Brazil and Argentina leading; adoption in agricultural biotechnology and academic research.
- Middle East & Africa: Emerging demand in UAE, Saudi Arabia, and South Africa; driven by healthcare modernization and genomic medicine initiatives.
Key Players
- Genescript
- GeneArt (Thermo Fisher Scientific)
- Integrated DNA Technologies (IDT)
- Eurofins Genomics
- DNA 2.0 (ATUM)
- BBI
- Genewiz
- Gene Oracle
- SBS Genetech
- Bio Basic
